PHARMACEUTICAL IP

  • Our Offering
    • Fractional IP counsel
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional IP counsel
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapy
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional IP counsel
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional IP counsel
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapy
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional IP counsel
  • Sectors
  • Evolve Insights
  • Our team
  • Join us
  • Our offering
  • Fractional IP counsel
  • Sectors
  • Evolve Insights
  • Our team
  • Join us

AI in the patent industry: Beware the MCP Trojan horse

  • Sector: Patent law
  • 11th September 2026
As patent attorneys, we should all know by now not to put client confidential information to a non-enterprise version of an LLM. However, as the capabilities of AI tools become more complex, so too does the necessity of understanding what exactly they are doing and where our data goes, beyond the simple prompt.

Originally posted on IPKat

 One such requirement is understanding the process by which AI tools silently retrieve information from the web and external databases in response to user queries via MCPs. Such processes often fall outside of the confidentiality provisions governed by the LLM per se. We therefore need to be asking our AI provider of choice what information is sent out to external parties, including web search engines and the confidentiality provisions associated with this. After all, web search is web search, whether this is a Google search, instructed by an LLM in response to a user query, or carried out by legal tech software sending instructions to a third-party tool.

LLMs and information retrieval

A large language model (LLM) is, at bottom, a text-in, text-out machine. Its knowledge is frozen at the point its training data stopped, it has no memory of your file, and in its raw state no way of looking anything up. Left to itself, asked about the prosecution history of a European application, it will produce something that reads exactly like a prosecution history and is very often fiction (Evolve Insights). An MCP is an agreed way of plugging an AI model into something else, whether a database, a search engine, a website or your own document system, so that the model can go and fetch what it needs rather than relying on whatever it happens to remember from its training.

An MCP server is a single connector, built either by whoever holds the data or by a third party wrapping a public API to that data. LLMs can engage with this connector, which sets out a menu of things the model may ask for, such as searching publications, fetching register information or downloading the file wrapper.

Readers who have used Claude, ChatGPT or Gemini in the last year will object that the models plainly do look things up. This is because most state-of-the-art LLMs now have web-search built in. In response to a query, they will conduct a web search and cite their sources. This built-in web search is an example of the mechanism operating behind MCPs. The model is not remembering or reading the internet. It is interpreting your query, calling a web search application, getting text back, and reasoning over whatever it received. The request sent by the LLM to the web search application, known as a tool call, is a short, structured instruction the model composes for itself, naming the tool it wants and the arguments to run it with. The web search application then executes it on the model’s behalf and feeds the answer back. This mechanism operates in the same way whatever the tool or application happens to be.

MCPs for patent work

The patent profession is unusually well served by public data. It is the name of the game that patents are published, and these publications are freely available for anyone to read from their open access database of choice. Patent prosecution for published cases may also be freely viewed and downloaded from patent office databases. As patent attorneys, we also need to be familiar with the databases of technical information relevant to our field, such as databases of sequences, chemical structures, clinical trials, drug approvals and regulatory guidance.

However, the information provided in most of these databases is difficult to access, either for providing to models during a training run or by connecting the models to a simple web search tool. This is why even the latest LLMs with access to web search struggle to reliably and accurately retrieve patent data. What a model can reach is only ever as good as the tools it has been handed, and a general web search is a blunt instrument for patent purposes. Much early disappointment with LLMs in patent work has really been disappointment with retrieval. Enter the MCP servers. MCP connectors to patent and scientific databases allow LLMs to access and accurately provide patent information in a way that is not possible either by model training or simple web search.

There are already many MCP servers available for patent work, including free connectors to the EPO’s Open Patent Services (OPS) API. Note, however, that whilst the data and the underlying API are provided by the patent office, the MCP server wrapping them is generally built and operated by someone else. You can also get MCP servers to connect your LLM of choice to scientific databases such as, for example, Pubmed, PubChem, NCBI BLAST sequence search and arXiv. Commercial patent intelligence databases and AI wrapper companies are also now offering their own MCP servers for LLMs.

So what’s the catch?

If you are using an LLM such as ChatGPT, Claude or Gemini for professional patent work you should be using an enterprise account to maintain the confidentiality of your client’s data. Information submitted to a free-to-use non-enterprise model is generally considered a non-confidential disclosure(Evolve Insights). If you are using an AI legal tech / AI wrapper company for professional patent work, your company of choice should have the necessary agreements in place with their LLM providers to preserve the confidentiality of users’ inputs. Of course, you also need an agreement with the AI wrapper company that they themselves will protect your data.

So how do MCPs fit into this? Looking first at the LLM providers themselves. If you connect your LLM to a third-party MCP server, this generally is not covered by the terms and conditions that govern your use of the model itself. This is essentially because the MCP provider is a third party in the relationship. For example, if you connect Claude to a third-party MCP server for patent search, you lose control of the data that Claude sends to the MCP server. As Anthropic states themselves: “Anthropic does not review, authorize, or assume responsibility for customer-registered MCP servers or the external systems they call”.

The information sent by the LLM to the MCP server, in the case of patent search, can contain very sensitive information, such as a description of the undisclosed invention, a proprietary sequence, a new disease target or other confidential client information. Connecting even an enterprise-level LLM account to a third-party MCP server is therefore effectively like submitting the details of the invention into a Google search or a free online database. Where the server is hosted by someone else, whoever operates it receives your tool calls and may log them. In a simpler example, the same is true if you enable web search in Gemini or Claude. The information is sent out to the third-party web search provider and may be logged by them in the manner of all web searches.

Why do we care?

In some respects, this problem is not new. As patent attorneys we know that it is generally best to avoid putting the specifics of an unfiled, novel invention into a public search engine. Whilst typing terms into a search engine does not typically constitute a “public disclosure”, it is generally considered to violate best practices for maintaining absolute confidentiality.

The first problem is data logging. Public search engines log queries, IP addresses, and user profiles. If the target involves a highly specific, newly identified protein name, gene sequence, or structural formulation, querying it directly transmits that data to a third-party server without a non-disclosure agreement.

The second problem is trade secret vulnerability. If you are holding the target as a trade secret whilst developing the assays or drug candidates, exposing the exact nomenclature or sequence to a public platform weakens the argument that reasonable steps were taken to keep the information secret. This is why you don’t submit a BLAST search for your newly invented antibody sequence.

Connecting to a third-party MCP server for database searches without specific confidentiality agreements with the MCP provider falls under exactly the same category.

The risks are real

So you are using a legal tech / IP AI wrapper company for patent work. You know they have confidentiality and no-data-retention agreements in place with their LLM providers. You also have a specific confidentiality agreement with the legal tech company themselves. So far so good.

However, most new legal tech companies will not have their own database of curated IP and scientific resources. They will therefore be using some form of MCP server to access patent and scientific databases. The next questions you need to be asking are therefore how they are accessing the data they are providing:

  • If they have access to the EPO and USPTO registers, what MCP server are they using and what agreements do they have in place with the MCP providers? Are the tool calls to the MCP provider logged?
  • Are they conducting web search based on users’ prompts, or allowing the underlying LLM to carry out web search? If so, what web searching tool are they using and what happens to the tool calls? A web search from an LLM may be equivalent, from a data logging perspective, to a web search on a public search engine.

Establishing this information is particularly important if you are using the tool to carry out invention disclosure assessments.

There are currently IP AI-wrapper companies which offer MCP connectors to their system from Claude (you generally need a subscription to both). The connectors say that they allows users to search across patent and non-patent literature, legal texts and case law, SEP technical standards, “and the open web”. However, we think it is unlikely that legal tech companies have built their own web search engines, or a comprehensive database of all the journal articles, theses, datasets and books. It seems likely, therefore, that MCP servers are in play. In order to be confident in submitting confidential client information such as an invention disclosure to these connectors, it is necessary to confirm that the data is not sent to third-party or web search engines, unless you would be similarly happy to submit the same information in a Google search.

Analysis

According to the epi Guidelines on the Use of Generative AI in the Work of Patent Attorneys, “Members must inform themselves about the likelihoods and modes of non-confidential disclosures deriving from use of specific AI models”. In the ever-changing AI landscape, this can be easier said than done. MCPs add yet more complexity for patent firms to navigate. The Trojan horse is that the connector arrives inside a carefully negotiated confidential arrangement and quietly carries the data back out again. Ironically, negotiating and putting in place a whole load of patent-related MCP servers with the required confidentiality provisions in place is one of the few things legal tech companies have to offer over and above the LLM providers themselves (Evolve Insights). Commercial databases of curated patent information may find that their value will lie almost exclusively in how well they enable users to connect to their databases from LLMs and how stringent their associated confidentiality provisions are. Perhaps someone could just offer this, minus the cost of a full subscription to wrapper functionality we no longer need?

Author: Rose Hughes

Rose is a biotech and pharmaceutical patent specialist with over a decade of experience in intellectual property. Rose is a patent attorney at Evolve, where she leverages our unique fractional in-house model to provide clients with deep patent law expertise combined with the strategic commercial oversight typically associated with senior in-house counsel.

With a PhD in Immunology from UCL, Rose applies her technical background to complex innovations in biologics, cell and gene therapies, and the rapidly emerging field of AI-assisted drug development. Previously, Rose held the role of Director. Patents at AstraZeneca, where she was responsible for global IP portfolios and IP strategy at every stage of the pharmaceutical pipeline, from platform development and on-market commercialization to SPCs and patent term extensions.

A recognized thought leader in the field, Rose has been a regular contributor to IPKat since 2018, offering practical insights into European patent law developments. She is also a frequent speaker on the epi podcast, a guest lecturer for the Brunel University IP law Postgrad Certificate, and a contributing author to published books A User’s Guide to Intellectual Property in Life Sciences (2021) and Developments and Directions in Intellectual Property Law (2023).

Related insights...

AI in the patent industry: Bubble trouble and the affordability myth

  • 20th July 2026
Whenever we write about AI, responses have started to move away from talk about hallucination, confidentiality or quality. The new concern is one of economics, i.e. will the whole AI thing just become too expensive and are we putting ourselves at risk by outsourcing to AI.

Podcast: Staring into the AI abyss

  • 14th July 2026
INSIGHT epi – The podcast for European patent professionals

Albert: AI-powered competitive intelligence and IP validity analysis for biotech & pharma

  • 23rd June 2026
Expert analysis based on deep industry expertise, delivered quickly and cost-effectively.

AI in the patent industry: Don’t believe the hype. Believe the data.

  • 9th June 2026
Many in the IP profession remain considerably sceptical of AI. AI may be useful for checking for typos and simple calculations of deadlines, but it cannot replace in-depth human reasoning about complex scientific and legal issues. However, the data suggests something different.

Popper: The global patent prosecution AI for pharmaceutical IP

  • 9th June 2026
Popper is Evolve’s proprietary AI tool, built by our own pharma patent attorneys to navigate the complex intersection of life sciences, global patent law, and commercial strategy.

Is AI software for IP just expensive wrapping paper?

  • 14th May 2026
At the last count, there were more than seventy companies offering AI-assisted IP software solutions. Most of these companies are less than two years old.

Are AI-generated materials legally privileged? United States v. Heppner

  • 13th May 2026
Legal privilege ensures that you can share sensitive information with your lawyers without fear of it being used against you in court. This protection is critical in all fields of law. In patent law, without the assurance of secrecy, the ability of a patentee or a defendant to receive candid advice would be severely diminished.…

The future of the patent profession: Are we looking into an AI abyss?

  • 8th May 2026
AI presents a huge dilemma for patent attorneys. There is no doubt that AI will have a dramatic impact on the profession and the business model that many firms have relied on for decades.

Use of AI in the patent industry: Are you behind the wheel or waiting for the bus?

  • 1st May 2026
It took a global pandemic to move some patent firms away from paper files. Today, it seems that patent attorneys are finally entering modernity with the growing adoption in the industry of automation tools for patent drafting and prosecution case management. Interestingly, much of this is being sold and promoted as “AI”, despite much of…

Use of AI in the patent industry: The spectre of hallucination

  • 10th October 2025
What are the risks of AI hallucinations for the patent industry?
All Insights

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2026 All Rights Reserved

Keep in touch

Subscribe

Contact Us